MHRA publishes the so-called "Brexit-guide"

The English medicines agency, Medicines and Healthcare products Regulatory Agency (MHRA), has published a guide addressing the position of the pharmaceutical and medical devices companies during the implementation period until the end of December 2020, when the UK will leave the EU.

The guide "What the implementation period means for the life science sector" outlines which arrangements will apply to, inter alia, batch release of pharmaceutical products, GMP, and CE marking of medical devices, as well as the implementation in the UK of the new EU regulations on clinical trials and medical devices.

MHRA's guide can be accessed here

Latest news on Life Science

Life Science